Superoxide Dismutases in Pancreatic Cancer

Overview

Journal Antioxidants (Basel)

Date 2017 Aug 22

PMID 28825637

Citations 7

Authors

Justin G Wilkes

Matthew S Alexander

Joseph J Cullen

Affiliations

Soon will be listed here.

Abstract

The incidence of pancreatic cancer is increasing as the population ages but treatment advancements continue to lag far behind. The majority of pancreatic cancer patients have a K- oncogene mutation causing a shift in the redox state of the cell, favoring malignant proliferation. This mutation is believed to lead to nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activation and superoxide overproduction, generating tumorigenic behavior. Superoxide dismutases (SODs) have been studied for their ability to manage the oxidative state of the cell by dismuting superoxide and inhibiting signals for pancreatic cancer growth. In particular, manganese superoxide dismutase has clearly shown importance in cell cycle regulation and has been found to be abnormally low in pancreatic cancer cells as well as the surrounding stromal tissue. Likewise, extracellular superoxide dismutase expression seems to favor suppression of pancreatic cancer growth. With an increased understanding of the redox behavior of pancreatic cancer and key regulators, new treatments are being developed with specific targets in mind. This review summarizes what is known about superoxide dismutases in pancreatic cancer and the most current treatment strategies to be advanced from this knowledge.

Citing Articles

Nimbolide Inhibits SOD2 to Control Pancreatic Ductal Adenocarcinoma Growth and Metastasis.

Mehmetoglu-Gurbuz T, Lakshmanaswamy R, Perez K, Sandoval M, Jimenez C, Rocha J Antioxidants (Basel). 2023; 12(10).

PMID: 37891871 PMC: 10604165. DOI: 10.3390/antiox12101791.

An In Vitro and In Silico Study of the Enhanced Antiproliferative and Pro-Oxidant Potential of L. cv. Arbosana Leaf Extract via Elastic Nanovesicles (Spanlastics).

Alnusaire T, Sayed A, Elmaidomy A, Al-Sanea M, Albogami S, Albqmi M Antioxidants (Basel). 2021; 10(12).

PMID: 34942963 PMC: 8698813. DOI: 10.3390/antiox10121860.

The Involvement of the Oxidative Stress Status in Cancer Pathology: A Double View on the Role of the Antioxidants.

Zahra K, Lefter R, Ali A, Abdellah E, Trus C, Ciobica A Oxid Med Cell Longev. 2021; 2021:9965916.

PMID: 34394838 PMC: 8360750. DOI: 10.1155/2021/9965916.

Iron protects childhood acute lymphoblastic leukemia cells from methotrexate cytotoxicity.

Abedi M, Rahgozar S, Esmaeili A Cancer Med. 2020; 9(10):3537-3550.

PMID: 32176452 PMC: 7221302. DOI: 10.1002/cam4.2982.

Use of Antimetastatic SOD3-Mimetic Albumin as a Primer in Triple Negative Breast Cancer.

Messerli S, Schaefer A, Zhuang Y, Soltys B, Keime N, Jin J J Oncol. 2019; 2019:3253696.

PMID: 30941174 PMC: 6420975. DOI: 10.1155/2019/3253696.

References

Oberley L, Buettner G . Role of superoxide dismutase in cancer: a review. Cancer Res. 1979; 39(4):1141-9. View

Hong Y, Kang H, Kwon S, Kim H, Kwon K, Cho C . Nuclear factor (erythroid-derived 2)-like 2 regulates drug resistance in pancreatic cancer cells. Pancreas. 2010; 39(4):463-72. PMC: 3506252. DOI: 10.1097/MPA.0b013e3181c31314. View

Lewis A, Du J, Liu J, Ritchie J, Oberley L, Cullen J . Metastatic progression of pancreatic cancer: changes in antioxidant enzymes and cell growth. Clin Exp Metastasis. 2006; 22(7):523-32. DOI: 10.1007/s10585-005-4919-7. View

Davidson N, Armstrong S, Coussens L, Cruz-Correa M, DeBerardinis R, Doroshow J . AACR Cancer Progress Report 2016. Clin Cancer Res. 2016; 22 Suppl 19:S1-S137. DOI: 10.1158/1078-0432.CCR-16-1993. View

Schoenfeld J, Sibenaller Z, Mapuskar K, Wagner B, Cramer-Morales K, Furqan M . O and HO-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological Ascorbate. Cancer Cell. 2017; 31(4):487-500.e8. PMC: 5497844. DOI: 10.1016/j.ccell.2017.02.018. View

Wang W, Abbruzzese J, Evans D, Larry L, Cleary K, Chiao P . The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells. Clin Cancer Res. 1999; 5(1):119-27. View

Ju H, Ying H, Tian T, Ling J, Fu J, Lu Y . Mutant Kras- and p16-regulated NOX4 activation overcomes metabolic checkpoints in development of pancreatic ductal adenocarcinoma. Nat Commun. 2017; 8:14437. PMC: 5333128. DOI: 10.1038/ncomms14437. View

Yang J, Li S, Domann F, Buettner G, Oberley L . Superoxide generation in v-Ha-ras-transduced human keratinocyte HaCaT cells. Mol Carcinog. 1999; 26(3):180-8. View

Marklund S, Holme E, Hellner L . Superoxide dismutase in extracellular fluids. Clin Chim Acta. 1982; 126(1):41-51. DOI: 10.1016/0009-8981(82)90360-6. View

10.

Lebovitz R, Zhang H, Vogel H, Cartwright Jr J, DIONNE L, Lu N . Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice. Proc Natl Acad Sci U S A. 1996; 93(18):9782-7. PMC: 38506. DOI: 10.1073/pnas.93.18.9782. View

11.

Uhlen M, Fagerberg L, Hallstrom B, Lindskog C, Oksvold P, Mardinoglu A . Proteomics. Tissue-based map of the human proteome. Science. 2015; 347(6220):1260419. DOI: 10.1126/science.1260419. View

12.

Buettner G . Superoxide dismutase in redox biology: the roles of superoxide and hydrogen peroxide. Anticancer Agents Med Chem. 2011; 11(4):341-6. PMC: 3131414. DOI: 10.2174/187152011795677544. View

13.

Shiga K, Hara M, Nagasaki T, Sato T, Takahashi H, Takeyama H . Cancer-Associated Fibroblasts: Their Characteristics and Their Roles in Tumor Growth. Cancers (Basel). 2015; 7(4):2443-58. PMC: 4695902. DOI: 10.3390/cancers7040902. View

14.

Cerutti P . Prooxidant states and tumor promotion. Science. 1985; 227(4685):375-81. DOI: 10.1126/science.2981433. View

15.

Che M, Wang R, Li X, Wang H, Zheng X . Expanding roles of superoxide dismutases in cell regulation and cancer. Drug Discov Today. 2015; 21(1):143-149. PMC: 4724522. DOI: 10.1016/j.drudis.2015.10.001. View

16.

Fetherolf M, Boyd S, Taylor A, Kim H, Wohlschlegel J, Blackburn N . Copper-zinc superoxide dismutase is activated through a sulfenic acid intermediate at a copper ion entry site. J Biol Chem. 2017; 292(29):12025-12040. PMC: 5519355. DOI: 10.1074/jbc.M117.775981. View

17.

Menon S, Goswami P . A redox cycle within the cell cycle: ring in the old with the new. Oncogene. 2006; 26(8):1101-9. DOI: 10.1038/sj.onc.1209895. View

18.

Siegel R, Miller K, Jemal A . Cancer Statistics, 2017. CA Cancer J Clin. 2017; 67(1):7-30. DOI: 10.3322/caac.21387. View

19.

Tang H, Dong X, Day R, Hassan M, Li D . Antioxidant genes, diabetes and dietary antioxidants in association with risk of pancreatic cancer. Carcinogenesis. 2010; 31(4):607-13. PMC: 2847085. DOI: 10.1093/carcin/bgp310. View

20.

Zong L, Li J, Chen X, Chen K, Li W, Li X . Lipoxin A4 Attenuates Cell Invasion by Inhibiting ROS/ERK/MMP Pathway in Pancreatic Cancer. Oxid Med Cell Longev. 2015; 2016:6815727. PMC: 4663743. DOI: 10.1155/2016/6815727. View